ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,013.13
-1.71%
US Tech 100
21,158.00
0.55%
다우존스 지수
43,428.02
-1.69%
Bitcoin
95,660.18
-0.64%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Sinovac Biotech Ltd (SVA) 시세

Sinovac Biotech Ltd

Sinovac Biotech Ltd (SVA)

Simavita Ltd
Sernova Biotherapeutics Inc
Sernova Corp
6.47
0.00
(0.00%)
마감 22 2월 6:00AM
15분 지연
6.47
0.00
( 0.00% )
시간외 단일가: 9:00AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
6.47
매수가
6.47
매도가
6.47
거래량
-
0.00 일간 변동폭 0.00
6.47 52주 범위 6.47
market_cap
460.272M
전일 종가
6.47
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
71,139,402
배당수익률
-
주가수익률
-1.78
주당순이익(EPS)
-3.63
매출
448.27M
순이익
-258.36M

Sinovac Biotech Ltd 정보

Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), ... Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.sinovac.com
본부
Saint John, Atg
설립됨
-
Sinovac Biotech Ltd is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker SVA. The last closing price for Sinovac Biotech was US$6.47. Over the last year, Sinovac Biotech shares have traded in a share price range of US$ 6.47 to US$ 6.47.

Sinovac Biotech currently has 71,139,402 shares in issue. The market capitalisation of Sinovac Biotech is US$460.27 million. Sinovac Biotech has a price to earnings ratio (PE ratio) of -1.78.

SVA 최신 뉴스

추가 뉴스

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
16 1월 2025
SVA (0.00%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
17 8월 2024
SVA (0.00%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1006.476.476.4700CS
4006.476.476.4700CS
12006.476.476.4700CS
26006.476.476.4700CS
52006.476.476.4700CS
156006.476.476.4700CS
260006.476.476.4700CS

SVA - Frequently Asked Questions (FAQ)

What is the current Sinovac Biotech share price?
The current share price of Sinovac Biotech is US$ 6.47
How many Sinovac Biotech shares are in issue?
Sinovac Biotech has 71,139,402 shares in issue
What is the market cap of Sinovac Biotech?
The market capitalisation of Sinovac Biotech is USD 460.27M
What is the 1 year trading range for Sinovac Biotech share price?
Sinovac Biotech has traded in the range of US$ 6.47 to US$ 6.47 during the past year
What is the PE ratio of Sinovac Biotech?
The price to earnings ratio of Sinovac Biotech is -1.78
What is the cash to sales ratio of Sinovac Biotech?
The cash to sales ratio of Sinovac Biotech is 1.03
What is the reporting currency for Sinovac Biotech?
Sinovac Biotech reports financial results in USD
What is the latest annual turnover for Sinovac Biotech?
The latest annual turnover of Sinovac Biotech is USD 448.27M
What is the latest annual profit for Sinovac Biotech?
The latest annual profit of Sinovac Biotech is USD -258.36M
What is the registered address of Sinovac Biotech?
The registered address for Sinovac Biotech is 36 LONG STREET, SAINT JOHN
What is the Sinovac Biotech website address?
The website address for Sinovac Biotech is www.sinovac.com
Which industry sector does Sinovac Biotech operate in?
Sinovac Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
VRMVroom Inc
US$ 24.50
(390.00%)
102
STECSantech Holdings Limited
US$ 2.04
(213.70%)
11.09M
RETOReTo Eco Solutions Inc
US$ 1.22
(200.57%)
5.78M
LINKInterlink Electronics Inc
US$ 13.00
(84.40%)
58
BSBKBogota Financial Corporation
US$ 12.49
(57.30%)
6
PHVSPharvaris NV
US$ 10.01
(-39.30%)
10
EBMTEagle Bancorp Montana Inc
US$ 12.01
(-33.35%)
22
ASTLAlgoma Steel Group Inc
US$ 5.20
(-31.31%)
401
HBNCHorizon Bancorp Inc
US$ 12.30
(-26.65%)
10
MATHMetalpha Technology Holding Ltd
US$ 1.62
(-23.58%)
741
STECSantech Holdings Limited
US$ 2.04
(213.70%)
11.09M
CNEYCN Energy Group Inc
US$ 0.3194
(30.58%)
8.8M
RETOReTo Eco Solutions Inc
US$ 1.22
(200.57%)
5.78M
ADTXAditxt Inc
US$ 0.0877
(-4.15%)
4.41M
HOLOMicroCloud Hologram Inc
US$ 1.84
(17.20%)
3.75M

SVA Discussion

게시물 보기
AlternativeLiquidity AlternativeLiquidity 1 년 전
Tender offer for Sinovac Shares:
https://www.sec.gov/Archives/edgar/data/1084201/000187041224000001/0001870412-24-000001-index.htm

Investor Letter:
https://www.sec.gov/Archives/edgar/data/1084201/000187041224000001/Exhibit_A3.htm

For investors that are sick of holding the shares, this might be a good opportunity to exit.

Annual reports and other public disclosures from the company are available here:

https://www.sec.gov/edgar/browse/?CIK=0001084201

👍️0
mick mick 1 년 전
https://www.otcmarkets.com/stock/SVA
👍️0
mick mick 1 년 전
https://www.otcmarkets.com/stock/SVA
👍️0
mick mick 1 년 전
https://www.otcmarkets.com/stock/SVA
👍️0
mick mick 1 년 전
https://www.otcmarkets.com/stock/SVA
👍️0
IHuser IHuser 1 년 전
imo... i guarantee my following will destroy this ticker....quickly...SVA

IHuser
👍️0
IHuser IHuser 1 년 전
imo... ya mick me and my boys own this market now.....gl...wont be a market soon~



IHuser
👍️0
mick mick 1 년 전
https://www.otcmarkets.com/stock/SVA
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 2 년 전
Date

Event

January 28, 2020

SINOVAC established and launched a new COVID-19 vaccine research and development project

June 13, 2020

SINOVAC announced a Phase I/II clinical study of its new COVID-19 vaccine, showing the vaccine was safe and effective in producing neutralizing antibodies

February 16, 2021

Professor Lau Chak-sing, Convener of the Hong Kong Vaccine Advisory Expert Committee, announced the committee’s review of data for CoronaVac®. Results showed CoronaVac® benefits outweigh the risks. The committee recommended the vaccine to the government

February 19, 2021

Within 72 hours after the advisory committee's recommendation, the first batch of one million doses of CoronaVac® arrived in Hong Kong from Beijing. Hong Kong subsequently launched a large-scale COVID-19 vaccination program

June 2, 2022

CoronaVac® was validated by the World Health Organization’s Emergency Use List Procedure

February 20, 2022

SINOVAC Foundation donations to Hong Kong helped local communities in the fight against the COVID-19 pandemic

April 14, 2022

In cooperation with HKU and Gleneagles Hospital, SINOVAC’s inactivated COVID-19 vaccine (omicron variant) was approved for clinical trials in Hong Kong

August 4, 2022

Children between the ages of 6 months and 3 years old were eligible for receiving CoronaVac®. To help the public complete their vaccinations as soon as possible, Hong Kong had opened up multiple new vaccination centers.

December 16, 2022

CoronaVac® was fully registered in Hong Kong under the Pharmacy and Poisons Ordinance Cap 138. It is one of the first COVID-19 vaccines approved for official registration in Hong Kong

May 10, 2023

SINOVAC announced the supply of the inactivated COVID-19 vaccine CoronaVac® (original strain) to Hong Kong’s private market, with plans to donate free COVID-19 vaccines to children

[1] HKSAR news.gov.hk: Professor Lo Chung Mo’s Chinese article dated 15 Sept 2022. https://www.news.gov.hk/chi/2022/09/20220915/20220915_145920_647.html

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.

SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps.

The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and was commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO.

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program.

SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations.

For more information, please see the Company’s website at www.sinovac.com.



View source version on businesswire.com: https://www.businesswire.com/news/home/20230510005485/en/

Sinovac Biotech Ltd.
PR Team
pr@sinovac.com
👍️0
mick mick 2 년 전
decrease in sales <> https://www.otcmarkets.com/filing/html?id=16605858&guid=_1T-knRCUJRXB3h
👍️0
mick mick 2 년 전
interesting review <> https://ih.advfn.com/stock-market/NASDAQ/sinovac-biotech-SVA/stock-news/91160230/amended-statement-of-beneficial-ownership-sc-13d-a

$SVA
👍️0
mick mick 2 년 전
Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/25/2023 11:14:28 AM
CoronaVac® von SINOVAC erfüllt Hongkongs Bedarf an COVID-19-Impfstoffen zur Selbstzahlung • Business Wire • 05/12/2023 04:22:00 PM
??????CoronaVac ®????????????COVID-19????????????????? • Business Wire • 05/10/2023 06:02:00 PM
Le vaccin CoronaVac® de SINOVAC répond au besoin pour des vaccins contre la COVID-19 autopayés à Hong Kong • Business Wire • 05/10/2023 06:02:00 PM
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 2 년 전
Sinovac ändert Plan für Aktionärsrechte • Business Wire • 02/22/2023 03:20:00 PM
Amended Securities Registration (section 12(b)) (8-a12b/a) • Edgar (US Regulatory) • 02/22/2023 11:31:40 AM
👍️0
mick mick 2 년 전
Recent SVA News
???????????????? • Business Wire • 02/23/2023 12:38:00 PM
Sinovac modifie le régime de droits des actionnaires • Business Wire • 02/22/2023 05:02:00 PM
Sinovac ändert Plan für Aktionärsrechte • Business Wire • 02/22/2023 03:20:00 PM
Amended Securities Registration (section 12(b)) (8-a12b/a) • Edgar (US Regulatory) • 02/22/2023 11:31:40 AM
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 2 년 전
$SVA http://www.sinovac.com/
👍️0
mick mick 2 년 전
SINOVAC Reports Unaudited First Half of 2022 Financial ResultsBUSINESS WIRE | 12/29/2022
👍️0
mick mick 2 년 전
FORM TYPE RECEIVED PERIOD END DATE REPORT
6-K 12/29/2022 12/29/2022 PDFRTFHTMLXLS
SC 13D/A 12/12/2022 PDFRTFHTMLXLS
6-K 11/04/2022 11/04/2022 PDFRTFHTML
6-K 06/09/2022 06/09/2022 PDFRTFHTML
6-K 05/06/2022 05/06/2022 PDFRTFHTML
6-K 05/02/2022 04/29/2022 PDFRTFHTMLXLS
20-F 04/29/2022 12/31/2021 PDFRTFHTMLXLS
8-A12B/A 02/22/2022 PDFRTFHTMLXLS
6-K 02/22/2022 02/22/2022 PDFRTFHTML
6-K 12/30/2021 12/30/2021 PDFRTFHTMLXLS
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 2 년 전
SVA Latest News
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 12/29/2022 08:41:47 AM
SINOVAC Reports Unaudited First Half of 2022 Financial Results 12/29/2022 08:30:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) 12/12/2022 06:45:09 AM
?????????????WHO???????? 11/04/2022 08:01:00 AM
👍️0
mick mick 2 년 전
https://www.otcmarkets.com/stock/SVA/security
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 2 년 전
https://www.otcmarkets.com/stock/SVA/disclosure
👍️0
mick mick 2 년 전
Recent SVA News
???????????????COVID-19????????????????????? • Business Wire • 09/07/2022 11:57:00 AM
SINOVAC erhält Genehmigung für klinische Studie zu seinem Omikron-COVID-19-Impfstoff in Chile • Business Wire • 09/06/2022 07:20:00 PM
SINOVAC autorisé à lancer au Chili un essai clinique pour son vaccin contre le variant Omicron du Covid-19 • Business Wire • 09/06/2022 02:03:00 PM
👍️0
mick mick 2 년 전
Recent SVA News
???????????????COVID-19????????????????????? • Business Wire • 09/07/2022 11:57:00 AM
SINOVAC erhält Genehmigung für klinische Studie zu seinem Omikron-COVID-19-Impfstoff in Chile • Business Wire • 09/06/2022 07:20:00 PM
SINOVAC autorisé à lancer au Chili un essai clinique pour son vaccin contre le variant Omicron du Covid-19 • Business Wire • 09/06/2022 02:03:00 PM
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
👍️0
mick mick 2 년 전
Recent SVA News
???????????????COVID-19????????????????????? • Business Wire • 09/07/2022 11:57:00 AM
SINOVAC erhält Genehmigung für klinische Studie zu seinem Omikron-COVID-19-Impfstoff in Chile • Business Wire • 09/06/2022 07:20:00 PM
SINOVAC autorisé à lancer au Chili un essai clinique pour son vaccin contre le variant Omicron du Covid-19 • Business Wire • 09/06/2022 02:03:00 PM
👍️0
mick mick 2 년 전
https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html?source=content_type%3Areact%7Cfirst_level_url%3Aarticle%7Csection%3Amain_content%7Cbutton%3Abody_link
Turkey signed a deal with Sinovac for 50 million doses of the vaccine. The first three million doses are scheduled to arrive Monday in Turkey,
Mr. Koca said. Mr. Koca said Turkey would also get 4.5 million doses of the Pfizer-BioNTech vaccine by the end of March.
Around 1 million doses are expected to arrive at the end of January, he said.
👍️0
mick mick 2 년 전
Contact: Stella Wang
Email: http://www.Stellawang@1globe-china.com
👍️0
mick mick 2 년 전
Contact: Stella Wang
Email: http://www.Stellawang@1globe-china.com
👍️0
mick mick 2 년 전
http://www.sinovac@sinovac.com
👍️0
mick mick 2 년 전
http://www.pr@sinovac.com
👍️0
mick mick 2 년 전
Recent SVA News
??????COVID-19??????????6????????????????? • Business Wire • 08/05/2022 06:19:00 PM
L'utilisation du vaccin anti-COVID-19 de SINOVAC approuvée à partir de l'âge de six mois à Hong Kong • Business Wire • 08/03/2022 04:45:00 PM
COVID-19-Impfstoff von SINOVAC in Hongkong zur Verwendung bei Kindern ab einem Alter von 6 Monaten zugelassen • Business Wire • 08/03/2022 04:45:00 PM
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong • Business Wire • 08/03/2022 10:00:00 AM
?????????4???????????????????? • Business Wire • 07/20/2022 12:00:00 PM
SINOVAC startet klinische Studie für seinen Vierfach-Grippeimpfstoff in Chile • Business Wire • 07/19/2022 01:31:00 PM
SINOVAC lance un essai clinique au Chili pour son vaccin antigrippal quadrivalent • Business Wire • 07/19/2022 11:16:00 AM
👍️0
mick mick 2 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
Bid: 6.93
Ask: 6.00
SVA Detailed Quote
👍️0
mick mick 3 년 전
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
Bid: 6.93
Ask: 6.10
SVA Detailed Quote
👍️0
mick mick 3 년 전
https://www.otcmarkets.com/stock/SVA/overview
👍️0
mick mick 3 년 전
https://www.otcmarkets.com/stock/SVA/overview
👍️0
mick mick 3 년 전
never answered e-mail $SVA
👍️0
mick mick 3 년 전
yes hope it does $SVA
👍️0
mick mick 3 년 전
$SVA News: COVID-19-Impfstoff von SINOVAC erhält in Brasilien Notfallzulassung für Kinder im Alter von 3 bis 5 Jahren 07/14/2022 01:36:00 PM
SVA News: Le vaccin SINOVAC contre le COVID-19 est autorisé pour une utilisation d’urgence chez les enfants âgés de 3 à 5 ans au Brésil 07/14/2022 01:00:00 PM
👍️0
mick mick 3 년 전
$SVA News: SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil 07/14/2022 11:02:00 AM
👍️0
mick mick 3 년 전
$SVA News: SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil 07/14/2022 05:10:00 AM
SVA News: SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa 06/25/2022 12:30:00 AM
👍️0

최근 히스토리

NASDAQ
SVA
Sinovac Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지